China's Landwind Device Maker Reported Target Of U.S. Acquisition
This article was originally published in PharmAsia News
Executive Summary
Chinese medical-device maker Landwind is said to be the target of an acquisition effort by the U.S.-based hedge fund, Avenue Capital
Chinese medical-device maker Landwind is said to be the target of an acquisition effort by the U.S.-based hedge fund, Avenue Capital. Sources said the deal for Landwind could be worth more than $100 million. Avenue Capital, working with Citi Venture Capital International, is reported to be in the last stage of acquisition talks after other would-be investors ceased bidding for the company. None of the parties involved would confirm the deal. (Click here for more) "Avenue Capital Nears Deal For China Medical Firm--Sources" - Reuters (U.K.) (10/20/09) |